Author

F. Bard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 3 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Assay:proteomics· 4 Research Focus:cell signaling & trafficking· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

F. Tay· 2 shared J. Chia· 2 shared A. A. Chaumet· 1 shared B. Yanes· 1 shared C. S. Verma· 1 shared D. J. Gill· 1 shared E. Rainero· 1 shared H. Walker· 1 shared

Activity by Year

2018-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

F. Tay

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The extracellular matrix supports breast cancer cell growth under amino acid starvation by promoting tyrosine catabolism

M. Nazemi, B. Yanes, M. Llanses Martinez, H. Walker, F. Bard, E. Rainero

This study shows that the extracellular matrix supports breast cancer cell growth under amino acid starvation by enhancing tyrosine catabolism through ECM uptake and lysosomal degradation.

bioRxiv · Jun 9, 2021 · PreprintCancer Biology

Src activates retrograde membrane traffic through phosphorylation of GBF1

J. Chia, S.-C. Wang, S. Wee, D. J. Gill, F. Tay, S. Kannan, C. S. Verma, J. Gunaratne, F. Bard

This study identifies how Src kinase promotes retrograde membrane traffic by phosphorylating GBF1, facilitating its interaction with Arf1 and enabling GALNTs relocation from Golgi to ER.

bioRxiv · Aug 2, 2020Cell Biology

Targeting c-Myc with a novel Peptide Nuclear Delivery Device

T. A. Ting, A. A. Chaumet, F. Bard

This paper develops a peptide nuclear delivery device (PNDD) that efficiently delivers c-Myc inhibitors to the nucleus, showing potent antitumor effects in lymphoma cell lines.

bioRxiv · Apr 7, 2020Cell Biology

The GalNAc-T Activation (GALA) Pathway: Drivers and Markers

J. Chia, F. Tay, F. Bard

The paper reanalyzes data to show EGF-induced GALNTs relocation is reproducible, identifies EGFR as a driver of the GALA pathway, and proposes PDIA4 glycosylation as a new marker.

bioRxiv · Aug 6, 2018Cell Biology